Fox Business Flash leading headlines are here. Check out whats clicking on FoxBusiness.com.
AstraZeneca Plc has offered its 7.7% stake in Moderna Inc for more than $1 billion after the U.S. biotechnology businesss shares soared on the back of its coronavirus vaccine advancement, The Times reported.TickerSecurityLastChangeChange %AZNASTRAZENECA PLC48.38-0.53 -1.08%MRNAMODERNA, INC. 154.81 +6.43 +4.33%The report added that it was unclear over what duration British-based AstraZeneca offered its holding in Moderna.AMID VACCINE DELAYS, ASTRAZENECA MAY HAVE BREACHED EU CONTRACT OVER COVID-19 SHOTSAstraZeneca and Moderna did not right away react to ask for comment.AstraZeneca Plc has actually sold its 7.7% stake in Moderna Inc for more than $1 billion after the U.S. biotechnology businesss shares skyrocketed on the back of its coronavirus vaccine breakthrough. (Melissa Melvin/AP Images for Tyson Foods File)AstraZeneca is keeping collaboration with Moderna on other illness treatments and might sell its AstraZeneca/Oxford University COVID-19 vaccine on an industrial basis in future if the virus ends up being endemic, the report added.Moderna, whose vaccine is cleared for emergency usage against COVID-19 in the United States, stated recently it was expecting sales of $18.4 billion from its coronavirus vaccine this year.

By